News for ANI Pharmaceuticals, Inc. (ANIP)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a...

ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE have been highlighted in this Screen of The Week article.

Investors need to pay close attention to ANI Pharmaceuticals (ANIP) stock based on the movements in the options market lately.

HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week article.

**media[582049]**

Is it a good or bad thing when a stock experiences a golden cross technical event?

ANI Pharmaceuticals Inc (ANIP) announced on March 18, 2025, that it has successfully completed the buyout of its 3.125% perpetual royalty obligation to SWK Fund

DALLAS, TX / ACCESS Newswire / March 19, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance compan

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) ( ANIP) today announced the launch of Nitazoxanide Tablets,

BAUDETTE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. ( ANIP) (ANI or the Company) today announced that it has completed the buyout of

**media[569332]**

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular ede

ANI Pharmaceuticals (ANIP) stock was granted an Overweight rating by J.P. Morgan on Wednesday based on the company's growth prospects. Read more here.

ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone are part of the Zacks Screen of the Week article.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here is how ANI Pharmaceuticals (ANIP) and Dynavax Technologies (DVAX) have performed compared to their sector so far this year.

On March 3, 2025, ANI Pharmaceuticals Inc (ANIP) announced that the U.S. Food and Drug Administration (FDA) has approved a new prefilled syringe format for its

**media[556117]**

Shares of ANI Pharmaceuticals Inc (ANIP) fell 3.82% in mid-day trading on Mar 3. The stock reached an intraday low of $59.01, before recovering slightly to $5